Radius Health, Inc. RDUS Income Statement

Radius health, inc. (RDUS)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
REVENUES:
Product revenue, net
47,923	-	-	-	29,844	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
OPERATING EXPENSES:
Cost of sales - product
3,861	4,478	3,971	3,808	3,030	2,743	2,193	1,603	1,088	574	253	105	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of sales - intangible amortization
200	198	200	200	200	199	200	200	200	200	200	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research and development
39,009	34,528	31,791	27,179	23,259	23,932	26,804	26,324	22,851	22,900	20,997	19,652	19,527	25,579	27,453	26,891	27,483	22,226	18,217	16,278	11,559	11,567	13,817	10,618	9,717	11,466	15,543	16,240	17,287	16,422	14,173	14,499	9,867	7,843	7,646	16,553	4,137	3,061	2,216
Selling, general and administrative
36,433	35,786	35,617	40,115	41,186	43,899	43,661	48,579	48,025	50,734	47,723	50,121	38,099	27,463	19,240	17,193	13,646	11,585	8,456	6,000	4,756	5,629	2,836	3,070	2,139	2,186	1,621	1,444	1,578	3,260	1,918	2,179	2,112	2,267	1,221	945	897	1,035	473
Other operating expense
-	-	0	0	-	-	0	10,801	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	470	-
Loss from operations
-31,580	-19,325	-24,813	-30,260	-37,831	-36,349	-45,219	-64,878	-57,617	-66,745	-55,704	-68,898	-57,626	-53,042	-46,693	-44,084	-41,129	-33,811	-26,673	-22,278	-16,315	-17,196	-16,653	-13,688	-11,856	-13,652	-17,164	-17,684	-18,865	-19,682	-16,091	-16,678	-11,979	-10,110	-8,867	-17,498	-5,034	-4,566	-2,689
OTHER INCOME (EXPENSE):
Other income (expense)
11	221	59	-42	4	-25	17	171	-104	20	-195	-97	80	-119	-78	-95	-1	92	1	-78	-50	-4	0	1,727	-2,233	1,620	-2,607	-1,184	11,256	-307	-604	-717	-467	43	-301	12	10	5	-15
Interest expense
6,756	6,435	6,298	6,165	6,037	5,913	5,793	5,683	5,566	5,535	2,763	0	0	-	0	-	-	0	294	794	797	814	802	450	401	502	582	658	698	787	853	584	443	-	258	108	-	-	-
Loss on retirement of note payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,572	-	-	-	0	-203	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
671	824	1,008	993	1,104	1,189	1,193	1,508	1,732	1,243	819	557	607	441	585	744	667	479	274	185	105	52	35	5	2	3	11	14	2	11	18	18	17	5	2	6	14	21	21
Net Income (Loss) Attributable to Parent
-37,654	-24,715	-30,044	-35,474	-42,760	-41,098	-49,802	-68,882	-61,555	-71,017	-57,843	-68,438	-56,939	-52,720	-46,186	-43,435	-40,463	-33,240	-28,264	-22,965	-17,057	-17,962	-17,420	-12,609	-14,488	-12,531	-20,342	-19,512	-8,305	-20,765	-17,530	-17,961	-12,872	-10,454	-9,424	-17,588	-5,010	-4,550	-
OTHER COMPREHENSIVE LOSS:
Unrealized gain (loss) from available-for-sale debt securities
-669	-18	66	236	474	94	442	192	-1,169	-315	-1	-32	-37	19	-136	-49	232	-94	89	-31	62	-	-11	1	-	-	-3	3	-	-3	-7	6	-1	-	-	-	-	-	-
COMPREHENSIVE LOSS
-38,323	-24,733	-29,978	-35,238	-42,286	-41,004	-49,360	-68,690	-62,724	-71,332	-57,844	-68,470	-56,976	-52,701	-46,322	-43,484	-40,231	-33,334	-28,175	-22,996	-16,995	-17,973	-17,431	-12,608	-14,488	-12,531	-20,345	-19,509	-8,305	-20,768	-17,537	-17,955	-12,873	-10,449	-9,424	-17,588	-5,007	-	-2,683
LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS - BASIC AND DILUTED (Note 8)
-37,654	-24,715	-30,044	-35,474	-42,760	-41,098	-49,802	-68,882	-61,555	-71,017	-57,843	-68,438	-56,939	139,590	46,186	-43,435	40,463	33,240	28,264	22,965	17,057	124,996	-17,420	-16,640	-19,457	-17,304	-25,090	-23,880	-11,887	-24,387	-21,090	-21,417	-16,226	18,688	-11,950	1,401	-7,886	-8,332	-5,399
Earnings Per Share [Abstract]
Earnings Per Share, Basic and Diluted
-0.81	-0.53	-0.65	-0.77	-0.94	-0.90	-1.09	-1.52	-1.37	-1.59	-1.31	-1.58	-1.32	-1.22	-1.07	-1.01	-0.94	-0.80	-0.68	-0.61	-0.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.59	-2.22	-50.45	-	-65.05	-62.59	-31.25	-	-24.53	-25.06	-20.92	42.22	-20.17	2.89	-24.43	-25.97	-16.85
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.59	-2.22	-50.45	-	-65.05	-62.59	-31.25	-	-24.53	-25.06	-20.92	44.23	-20.17	0.44	-24.43	-25.97	-16.85
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Basic and Diluted
46,271	46,182	46,141	46,109	45,671	45,557	45,498	45,430	44,937	44,623	43,999	43,410	43,185	43,123	43,092	43,042	43,012	43,076	41,331	37,895	36,268	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29,746	7,500	385	-	385	381	380	-	859	854	775	600	592	484	322	320	320
Diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	29,746	7,500	385	-	385	381	380	-	859	854	775	9,726	592	3,175	322	320	320
Product
Revenue from Contract with Customer, Excluding Assessed Tax
-	-	46,766	41,042	-	34,424	27,639	22,629	14,547	7,663	3,469	980	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
License
Revenue from Contract with Customer, Excluding Assessed Tax
-	-	-	-	-	-	-	-	-	-	10,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-